Back to Results
First PageMeta Content
Medicine / Medical emergencies / Heart diseases / Cardiomyopathy / Heart failure / Organ failure / Myocardial infarction / Ventricular remodeling / Cardiovascular disease / Circulatory system / Cardiology / Aging-associated diseases


IKARIA® COMMENCES GLOBAL REGISTRATION TRIAL FOR BIOABSORBABLE CARDIAC MATRIX - PRESERVATION I Investigates Novel Device for Cardiac Remodeling and Congestive Heart Failure Hampton, NJ – January 3, 2012 – Ikaria, Inc
Add to Reading List

Document Date: 2012-01-03 11:26:01

Open Document

File Size: 135,67 KB

Share Result on Facebook

City

Madison / Hampton / /

Company

BioLineRx Ltd. / Ikaria Inc. / /

Continent

Europe / /

Country

Puerto Rico / Japan / Canada / Australia / Israel / Mexico / /

Currency

USD / /

Event

M&A / FDA Phase / /

Facility

Port Allen / /

IndustryTerm

drug product / treatment of hypoxic respiratory failure / manufacturing facilities / treatment for hepatorenal syndrome / /

MedicalCondition

congestive heart failure / acute ST-segment elevation myocardial infarction / pulmonary hypertension / subsequent congestive heart failure / severe heart disease / hypoxic respiratory failure / Congestive Heart Failure After Acute Myocardial Infarction / acute heart attack / acute myocardial infarction / /

MedicalTreatment

catheterization / innovative therapies / /

Organization

FDA / American Heart Association / /

Person

Douglas Greene / /

Position

Governor / Executive Vice President of Research & Development / /

Product

INOMAX / Ikaria / /

ProvinceOrState

New Jersey / Wisconsin / /

URL

www.ikaria.com / www.clinicaltrials.gov / /

SocialTag